Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in EDIT — Editas Medicine, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$300,817
+$120,248 QoQ
Shares Held
92,845
+27.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Derivatives in EDIT

reported options exposure · as of Jun 30, 2026
CallValue
$1,521,180
CallShares
469,500
PutValue
$558,900
PutShares
172,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. EDIT ranks #198 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in EDIT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $558,900 172,500
2026-06-30 $1,521,180 469,500
2026-06-30 $300,817 92,845
2026-03-31 $228,475 92,500
2026-03-31 $481,897 195,100
2026-03-31 $180,569 73,105
2025-12-31 $224,885 109,700
2025-12-31 $1,444,556 704,662
2025-12-31 $71,750 35,000
2025-09-30 $274,824 79,200
2025-09-30 $2,773,258 799,210
2025-09-30 $220,345 63,500
2025-06-30 $2,076,558 943,890
2025-06-30 $241,120 109,600
2025-06-30 $163,020 74,100
2025-03-31 $121,916 105,100
2025-03-31 $174,116 150,100
2025-03-31 $678,640 585,035
2024-12-31 $43,942 34,600
2024-12-31 $97,155 76,500
2024-12-31 $559,589 440,622
2024-09-30 $1,139,700 334,223
2024-09-30 $167,090 49,000
2024-09-30 $515,251 151,100
2024-06-30 $650,998 139,400
2024-06-30 $327,834 70,200
2024-06-30 $1,462,629 313,197
2024-03-31 $1,601,978 215,900
2024-03-31 $1,560,782 210,348
2024-03-31 $2,055,340 277,000
2023-12-31 $4,039,844 398,800
2023-12-31 $1,861,894 183,800
2023-12-31 $691,098 68,223
2023-09-30 $439,920 56,400
2023-09-30 $2,703,431 346,594
2023-09-30 $967,980 124,100
2023-06-30 $1,103,643 134,100
2023-06-30 $461,703 56,100
2023-06-30 $2,209,482 268,467
2023-03-31 $580,000 80,000
2023-03-31 $503,875 69,500
2023-03-31 $1,844,674 254,438
2022-12-31 $992,295 111,871
2022-12-31 $2,164,280 244,000
2022-12-31 $1,641,837 185,100
2022-09-30 $2,352,528 192,200
2022-09-30 $2,981,664 243,600
2022-09-30 $4,783,294 390,792
2022-06-30 $3,065,140 259,099
2022-06-30 $2,597,868 219,600